MC
NUS icon

Maplelane Capital’s Nu Skin NUS Stock Holding History

Maplelane Capital’s Portfolio NUS Stock Details NUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-1
Closed – – 166
2017
Q2 		$0 Buy
+1
New +$57 ﹤0.01% 170

Other funds holding NUS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AL
AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return
PGP
Prescott General Partners Boca Raton, Florida $1.37B AUM 23.81% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Maplelane Capital's NUS Position: Q3 2017 in Review

Maplelane Capital sold out of Nu Skin (NUS) in Q3 2017, closing a stake of 1 share.

Maplelane Capital first reported a position in NUS in Q2 2017 and held it in 1 quarter. The position peaked at $0 in Q2 2017. 255 funds tracked by Wall St. Rank hold NUS as of Q3 2017.

  • Maplelane Capital reported no remaining Nu Skin position as of Q3 2017 after selling out during the quarter.
  • Maplelane Capital sold 1 Nu Skin share in Q3 2017.
  • Maplelane Capital first reported a position in Nu Skin in Q2 2017 and held it in 1 quarter.
  • Maplelane Capital's Nu Skin position peaked at $0 in Q2 2017.
  • 255 funds tracked by Wall St. Rank held Nu Skin as of Q3 2017.

Based on Maplelane Capital's 13F filing for Q3 2017, filed 14 Nov 2017.